Y100 Mitochondrial Biogenesis
Skin rejuvenation/restoration
Key Facts
About Zylo Therapeutics
Zylö Therapeutics is a private, pre-revenue biotech company specializing in advanced topical drug delivery. Its core innovation is the Z-pods® platform—porous silica particles that encapsulate actives to provide sustained release over up to 24 hours, enhance penetration into the stratum corneum and hair follicles, and improve the solubility and stability of drugs. The company operates as a platform technology provider, seeking partnerships with cosmetic, OTC, and pharmaceutical companies to enhance their topical products, with initial applications targeting dermatology and skincare. While still in pre-clinical and development stages, Zylö has validated its technology through multiple studies and is actively pursuing commercial collaborations.
View full company profile